Stockreport

ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com
PDF More than two-thirds of the expected number of patients have been enrolled in the TRYbeCA-1 Phase 3 clinical trialCash position of €73.2 million ($82.2 million) at the e [Read more]